TBK1 Gene Mutation clinical trials at UCSF

1 research study open to eligible people

A TBK1 gene mutation is a DNA change that alters a protein needed for cell health. UCSF is conducting research that measures thinking, speech, and behavior in people with TBK1 mutations. UCSF is collecting brain scans, blood, and detailed clinical records for study.

Showing trials for

  • ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

    open to eligible people ages 18 years and up

    ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.

    San Francisco, California and other locations

Our lead scientists for TBK1 Gene Mutation research studies include .

Last updated: